New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
09:10 EDTBIIB, MLNX, LTD, KSS, SPWR, TGT, JWN, ROST, FDO, GPSOn The Fly: Pre-market Movers
HIGHER AFTER SSS REPORTS: Ross Stores (ROST), up 5.1%... Nordstrom (JWN), up 3.5%... Target (TGT), up 2.9%... ALSO HIGHER: Gap (GPS), up 4% after report of December SSS up 5%, along with $1B stock-buyback plan and deal to buy Intermix for $130M... SunPower (SPWR), up 15.5% after upgrade to Buy at Lazard Capital... LOWER AFTER EARNINGS: Family Dollar (FDO), down 9.6%... LOWER AFTER SSS REPORTS: Limited (LTD), down 5%... Kohl's (KSS), down 2.4%... ALSO LOWER: Melanox (MLNX), down 18.6% after Q4 revenue warning prompts numerous price target cuts around Street... Biogen Idec (BIIB), down 5.4% after ALS drug misses endpoint, development discontinued.
News For GPS;FDO;ROST;JWN;TGT;SPWR;KSS;LTD;MLNX;BIIB From The Last 14 Days
Check below for free stories on GPS;FDO;ROST;JWN;TGT;SPWR;KSS;LTD;MLNX;BIIB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 11, 2014
07:31 EDTBIIBBiogen announces 5-year results from TECFIDERA ENDORSE Phase 3 study
Subscribe for More Information
07:31 EDTBIIBBiogen announces new data from Plegridy Phase 3 ADVANCE trial
Biogen Idec announced new data from the second year of its Phase 3 ADVANCE clinical trial that show the positive treatment effects of PLEGRIDY were maintained in people with relapsing forms of multiple sclerosis beyond the first year of the study. These results were presented at the sixth Triennial Joint Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee for Treatment and Research in Multiple Sclerosis in Boston. Post-hoc analyses from the two-year, Phase 3 ADVANCE clinical trial confirm that PLEGRIDYís positive effects on reducing disease activity and disability progression were maintained in year two of the study. A significantly higher proportion of patients taking PLEGRIDY during both years of the study experienced no evidence of disease activity Ė defined as the absence of clinical and MRI disease activity over two years of treatment Ė compared to those who switched to PLEGRIDY from placebo. Also, those treated with PLEGRIDY for both years of the study had significant reductions in the risk of 24-week confirmed disability progression compared to patients treated with placebo during the first year. In addition, new data from the second year of ADVANCE show that patients who took PLEGRIDY throughout the study experienced statistically significant improvements in clinical and MRI outcomes Ė including annualized relapse rate, risk of relapse, risk of 24-week confirmed disability progression, and number of brain lesions Ė when compared to those who switched to PLEGRIDY after taking placebo for the first year. This new data also showed that the safety profile of PLEGRIDY was consistent between years one and two of the study.
06:38 EDTGPSApple hires Gap's Marcela Aguilar for marketing role, Ad Age reports
Subscribe for More Information
September 10, 2014
13:03 EDTFDOOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday, with the Nasdaq comfortably the leader among the major averages. The market opened relatively quietly as investors digested the bevy of research reports surrounding apple (AAPL) and the companies effected by its new products and services announced yesterday. The averages crossed into negative ground early in trading, made it back to positive territory just before the lunch hour, and now are all in the black. ECONOMIC EVENTS: In the U.S., wholesale inventories rose 0.1% in July, which was below expectations for an increase of 0.5%. Wholesale sales rose 0.7%, which was above the 0.6% increase that was forecast. COMPANY NEWS: The strength in the Nasdaq was largely attributable to Apple, which rose about 2.5% the day after unveiling two new, larger iPhone 6 models, the Apple Watch and a new payment system, named Apple Pay... Dollar General (DG) "went hostile" in its pursuit of peer Family Dollar (FDO), commencing a tender offer to acquire all of the company's outstanding shares for $80.00 per share in cash. Family Dollar confirmed the unsolicited offer, noting that the terms are the same as those in the previously rejected proposal made by Dollar General on September 2. Family Dollar said its board will review and consider Dollar Generalís tender offer, but added that the board has not changed its recommendation in support of the company's merger with Dollar Tree (DLTR). MAJOR MOVERS: Among the notable gainers was NPS Pharmaceuticals (NPSP), which rose 21% after several analysts said FDA briefing documents for an advisory panel meeting on its Natpara drug were more favorable than expected. Also higher was clothing and accessories retailer Land's End (LE), which gained nearly 17% after the company's second quarter results beat the estimate of the only analyst that covers it. Among the noteworthy losers was eBay (EBAY), which fell for a second straight day after Apple announced its new mobile payment system, Apple Pay, that could come in direct competition with eBay's PayPal service. Shares of PayPal's parent were downgraded to Neutral this morning at Piper Jaffray and fell 3% near noon. Also lower following yesterday's presentation by Apple was partner GT Advanced (GTAT), which was downgraded at Goldman, Piper Jaffray and Dougherty and dropped more than 14% after it was revealed that sapphire will be used in the display cover of Apple Watch but not the iPhone 6. INDEXES: Near midday, the Dow was up 16.02, or 0.09%, to 17,029.89, the Nasdaq was up 21.10, or 0.46%, to 4,573.38, and the S&P 500 was up 2.62, or 0.13%, to 1,991.06.
11:43 EDTKSSLand's End soars after better than expected Q2 results
Subscribe for More Information
10:08 EDTFDOFamily Dollar confirms Dollar General unsolicited tender offer
Subscribe for More Information
10:06 EDTFDOFamily Dollar confirms Dollar General unsolicited tender offer
09:27 EDTFDODollar General tender for Family Dollar a logical next step, says Wells Fargo
Subscribe for More Information
07:01 EDTKSSKohl's announces Juicy Couture now available at stores nationwide
Kohlís announced that Juicy Couture is now available at Kohlís stores nationwide and Kohls.com/JuicyCouture. Kohlís is supporting the launch of Juicy Couture with a marketing campaign that includes a new partnership with Refinery29. For the first time, Kohlís is engaging the influential and popular online lifestyle destination to partner with key trend-setting bloggers and to host celebratory events. There will also be print, broadcast and digital advertising and social initiatives.
06:19 EDTFDODollar General commences tender offer to acquire Family Dollar for $80/share
Dollar General (DG) announced that it has commenced a tender offer to acquire all outstanding shares of Family Dollar Stores (FDO) for $80.00 per share in cash. The offer is scheduled to expire at 5:00 p.m., New York City time, on October 8, 2014, unless the offer is extended. The full terms, conditions and other details of the tender offer are set forth in the offering documents that Dollar General will file today with the SEC. Dollar General also will promptly file for clearance under the Hart-Scott-Rodino Act, which will allow the company to begin the antitrust approval process with the FTC. Dollar Generalís all-cash offer of $80.00 per share provides Family Dollar shareholders with a "superior valuation" to the $74.50 per share cash / stock offer announced by Dollar Tree (DLTR) on July 28, 2014. Dollar Generalís offer provides Family Dollarís shareholders with approximately $640M of additional aggregate value over Dollar Treeís offer. As part of a definitive merger agreement with Family Dollar, Dollar General would be willing to agree to divest up to 1,500 stores if required by the FTC and to pay Family Dollar a $500M reverse break-up fee if the transaction did not close for reasons related to antitrust approvals.
06:01 EDTFDODollar General commences tender offer to acquire Family Dollar for $80/share
Subscribe for More Information
September 9, 2014
16:15 EDTTGTTarget CEO to narrow focus to re-energize 'signature' categories, WSJ says
Subscribe for More Information
13:58 EDTTGTStarbucks, Groupon, OpenTable apps among those to integrate Apple Pay
Subscribe for More Information
09:22 EDTMLNXMellanox storage opportunity underappreciated, says Summit Research
Subscribe for More Information
08:33 EDTFDODollar Tree, Family Dollar receive second request from FTC under HSR Act
Subscribe for More Information
September 8, 2014
12:29 EDTTGTHome Depot victim of same malware that hit Target, Krebs reports
Subscribe for More Information
10:06 EDTGPSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:27 EDTBIIBLeerink biotech analyst holds a luncheon meeting with a conference call
Biotech Analyst Schwartz provides an update on key trends and controversies for marketed MS therapies and discusses new data presented at ACTRIMS-ECTRIMS at a Luncheon Meeting with an Analyst/Industry conference call to be held in Boston on September 11 at 12:15 pm.
09:18 EDTGPSGap downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill downgraded Gap to Underperform based on expectations it will miss full year guidance and consensus expectations. The firm said lower than expected August comps due not bode well for turnaround and lowered its full year EPS estimate to $2.85 from $2.96, vs. guidance of $2.95-$3.00.
07:15 EDTBIIBIBC Life Sciences to hold a conference
10th Annual Cell Line Development & Engineering Conference to be held in Berkeley, California on September 8-10.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use